AIGERIM B SAULEBAYEVA

Allopathic & Osteopathic Physicians|Ophthalmology NEW RICHMOND, WI NPI 1043744196

General Payments — all program years on this page

$8,076.03

  • Category: General Payments
  • Program years: PY2018–2023
  • Record count: 50
  • As of (CMS publication): 2026-01-23

Latest program year (PY2023): $5,755.71 across 13 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2023) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $4,935.001
Food and Beverage $626.1111
Travel and Lodging $194.601

By paying entity

Latest program year (PY2023) · sorted by reported total.

Paying entityAmountRecords
Genentech USA, Inc. $5,474.515
Apellis Pharmaceuticals, Inc. $164.013
Astellas Pharma US Inc $52.112
Biogen, Inc. $45.032
ABBVIE INC. $20.051

By program year

Program yearAmountRecords
2018 $452.615
2019 $820.008
2020 $103.924
2021 $562.2210
2022 $381.5710
2023 $5,755.7113

Records — PY2023 (13)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1012200671 Biogen, Inc. $18.05 01/18/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1012200677 Biogen, Inc. $26.98 02/28/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1034535863 Astellas Pharma US Inc $26.08 09/25/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1034655241 Astellas Pharma US Inc $26.03 11/09/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1040283561 Genentech USA, Inc. $20.72 05/03/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1040283569 Genentech USA, Inc. $194.60 04/12/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1040283577 Genentech USA, Inc. $199.19 04/12/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1040283585 Genentech USA, Inc. $4,935.00 04/12/2023 Consulting Fee Undisputed 01/23/2026 View at CMS
1040283593 Genentech USA, Inc. $125.00 06/21/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1056321859 Apellis Pharmaceuticals, Inc. $102.91 06/05/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1056327589 Apellis Pharmaceuticals, Inc. $27.54 04/24/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1056374199 Apellis Pharmaceuticals, Inc. $33.56 06/14/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
998835759 AbbVie Inc. $20.05 05/18/2023 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.